Assessment of the relationship between food addiction and nutritional status in schizophrenic patients

References

• Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016;388(10039):86–97.
   PubMed Web of Science ®Google Scholar
• Heald A, Pendlebury J, Anderson S, Narayan V, Guy M, Gibson M, et al. Lifestyle factors and the metabolic syndrome in schizophrenia: a cross-sectional study. Ann Gen Psychiatry 2017;16(1):502.
   Web of Science ®Google Scholar
• Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 2013;47(2):197–207.
   PubMed Web of Science ®Google Scholar
• Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: a national institute of mental health meeting report. Am J Prev Med 2009;36(4):341–50.
   PubMed Web of Science ®Google Scholar
• Li Q, Du X, Zhang Y, Yin G, Zhang G, Walss-Bass C, et al. The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia. Psychiatry Res 2017;251:131–6.
   PubMed Web of Science ®Google Scholar
• Wirshing DA. Schizophrenia and obesity: impact of antipsychotic medications. J Clin Psychiatry 2004;65(Suppl. 18):13–26.
   PubMed Web of Science ®Google Scholar
• Hert DE M, Schreurs V, Vancampfort D, VAN Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009;8(1):15–22.
   PubMed Web of Science ®Google Scholar
• Manu P, Dima L, Shulman M, Vancampfort D, De Hert M, Correll CU. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand 2015;132(2):97–108.
   PubMed Web of Science ®Google Scholar
• Roick C, Fritz-Wieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007;42(4):268–76.
   PubMed Web of Science ®Google Scholar
• Subramaniam M, Lam M, Guo ME, He VYF, Lee J, Verma S, et al. Body mass index, obesity, and psychopathology in patients with schizophrenia. J Clin Psychopharmacol 2014;34(1):40–6.
   PubMed Web of Science ®Google Scholar
• Gearhardt AN, Boswell RG, White MA. The association of “food addiction” with disordered eating and body mass index. Eat Behav 2014;15(3):427–33.
   PubMed Web of Science ®Google Scholar
• Hone-Blanchet A, Fecteau S. Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies. Neuropharmacology 2014;85:81–90.
   PubMed Web of Science ®Google Scholar
• Meule A. Food addiction and body-mass-index: a non-linear relationship. Med Hypotheses 2012;79(4):508–11.
   PubMed Web of Science ®Google Scholar
• Pursey K, Stanwell P, Gearhardt A, Collins C, Burrows T. The prevalence of food addiction as assessed by the Yale food addiction scale: a systematic review. Nutrients 2014;6(10):4552–90.
   PubMed Web of Science ®Google Scholar
• Eichen DM, Lent MR, Goldbacher E, Foster GD. Exploration of “food addiction” in overweight and obese treatment-seeking adults. Appetite 2013;67:22–4.
   PubMed Web of Science ®Google Scholar
• Hauck C, Weiß A, Schulte EM, Meule A, Ellrott T. Prevalence of “food addiction” as measured with the Yale food addiction scale 2.0 in a representative German sample and its association with sex, age and weight categories. Obes Facts 2017;10(1):12–24.
   PubMed Web of Science ®Google Scholar
• Murphy CM, Stojek MK, MacKillop J. Interrelationships among impulsive personality traits, food addiction, and body mass index. Appetite 2014;73:45–50.
   PubMed Web of Science ®Google Scholar
• Da Silva Alves F, Bakker G, Schmitz N, Abeling N, Hasler G, van der Meer J, et al. Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study. Eur Neuropsychopharmacol 2013;23(11):1577–86.
   PubMed Web of Science ®Google Scholar
• Meisenzahl EM, Schmitt GJ, Scheuerecker J, Möller HJ. The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry 2007;19(4):337–45.
   PubMed Web of Science ®Google Scholar
• Richter A, Petrovic A, Diekhof EK, Trost S, Wolter S, Gruber O. Hyperresponsivity and impaired prefrontal control of the mesolimbic reward system in schizophrenia. J Psychiatr Res 2015;71:8–15.
   PubMed Web of Science ®Google Scholar
• Tardieu S, Micallef J, Gentile S, Blin O. Weight gain profiles of new anti-psychotics: public health consequences. Obes Rev 2003;4(3):129–38.
   PubMedGoogle Scholar
• Amani R. Is dietary pattern of schizophrenia patients different from healthy subjects? BMC Psychiatry 2007;7(1):404.
   Web of Science ®Google Scholar
• Stokes C, Peet M. Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms. Nutr Neurosci 2004;7(4):247–9.
   PubMed Web of Science ®Google Scholar
• Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29(3):697–701.
   PubMed Web of Science ®Google Scholar
• McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003;183:534–9.
   PubMed Web of Science ®Google Scholar
• Ratliff JC, Palmese LB, Reutenauer EL, Liskov E, Grilo CM, Tek C. The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr Psychiatry 2012;53(7):1028–33.
   PubMed Web of Science ®Google Scholar
• Madden AM, Smith S. Body composition and morphological assessment of nutritional status in adults: a review of anthropometric variables. J Hum Nutr Diet 2016;29(1):7–25.
   PubMed Web of Science ®Google Scholar
• Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005;56(5):303–7.
   PubMed Web of Science ®Google Scholar
• Gearhardt AN, Corbin WR, Brownell KD. Preliminary validation of the Yale food addiction scale. Appetite 2009;52(2):430–6.
   PubMed Web of Science ®Google Scholar
• Chao AM, Shaw JA, Pearl RL, Alamuddin N, Hopkins CM, Bakizada ZM, et al. Prevalence and psychosocial correlates of food addiction in persons with obesity seeking weight reduction. Compr Psychiatry 2017;73:97–104.
   PubMed Web of Science ®Google Scholar
• Meule A, von Rezori V, Blechert J. Food addiction and bulimia nervosa. Eur Eat Disord Rev 2014;22(5):331–7.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Laz TH, Pohlmeier AM, Rahman M, Cunningham KA. Prevalence of food addiction among low-income reproductive-aged women. J Womens Health 2015;24(9):740–4.
   Web of Science ®Google Scholar
• Yu Z, Tan M. Disordered eating behaviors and food addiction among nutrition major college students. Nutrients 2016;8(11):673.
   Web of Science ®Google Scholar
• Pursey KM, Gearhardt AN, Burrows TL. The relationship between “food addiction” and visceral adiposity in young females. Physiol Behav 2016;157:9–12.
   PubMed Web of Science ®Google Scholar
• Brunault P, Ducluzeau P-H, Bourbao-Tournois C, Delbachian I, Couet C, Réveillère C, et al. Food addiction in bariatric surgery candidates: prevalence and risk factors. Obes Surg 2016;26(7):1650–3.
   PubMed Web of Science ®Google Scholar
• Pepino MY, Stein RI, Eagon JC, Klein S. Bariatric surgery-induced weight loss causes remission of food addiction in extreme obesity. Obesity 2014;22(8):1792–8.
   PubMed Web of Science ®Google Scholar
• Gearhardt AN, White MA, Masheb RM, Morgan PT, Crosby RD, Grilo CM. An examination of the food addiction construct in obese patients with binge eating disorder. Int J Eat Disord 2012;45(5):657–63.
   PubMed Web of Science ®Google Scholar
• de Vries S-K, Meule A. Food addiction and bulimia nervosa: new data based on the Yale food addiction scale 2.0. Eur Eat Disord Rev 2016;24(6):518–22.
   PubMed Web of Science ®Google Scholar
• Meule A, Hermann T, Kübler A. Food addiction in overweight and obese adolescents seeking weight-loss treatment. Eur Eat Disord Rev 2015;23(3):193–8.
   PubMed Web of Science ®Google Scholar
• Meule A, de Zwaan M, Müller A. Attentional and motor impulsivity interactively predict “food addiction” in obese individuals. Compr Psychiatry 2017;72:83–7.
   PubMed Web of Science ®Google Scholar
• Pedram P, Wadden D, Amini P, Gulliver W, Randell E, Cahill F, et al. Food addiction: its prevalence and significant association with obesity in the general population. PLoS ONE 2013;8(9):e74832.
   PubMed Web of Science ®Google Scholar
• Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, et al. Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: a nationwide survey. Schizophr Res 2016;171(1–3):68–73.
   PubMed Web of Science ®Google Scholar
• Bradshaw T, Mairs H. Obesity and serious mental ill health: a critical review of the literature. Healthcare 2014;2(2):166–82.
   Google Scholar
• Limosin F, Gasquet I, Leguay D, Azorin JM, Rouillon F. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia. Acta Psychiatr Scand 2008;118(1):19–25.
   PubMed Web of Science ®Google Scholar
• Lee A, Gibbs SE. Neurobiology of food addiction and adolescent obesity prevention in low- and middle-income countries. J Adolesc Health 2013;52(Suppl. 2):S39–42.
   PubMed Web of Science ®Google Scholar
• MacNicol B. The biology of addiction. Can J Anesth 2017;64(2):141–8.
   PubMed Web of Science ®Google Scholar
• Blumenthal DM, Gold MS. Neurobiology of food addiction. Curr Opin Clin Nutr Metab Care 2010;13(4):359–65.
   PubMed Web of Science ®Google Scholar
• Leigh SJ, Morris MJ. The role of reward circuitry and food addiction in the obesity epidemic: an update. Biol Psychol 2016. doi:10.1016/j.biopsycho.2016.12.013.
   PubMed Web of Science ®Google Scholar
• Grimm O, Kaiser S, Plichta MM, Tobler PN. Altered reward anticipation: potential explanation for weight gain in schizophrenia? Neurosci Biobehav Rev 2017;75:91–103.
   PubMed Web of Science ®Google Scholar
• Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wustenberg T, Villringer A, et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology 2006;187(2):222–8.
   PubMed Web of Science ®Google Scholar
• Zhuo C, Zhu J, Wang C, Qu H, Ma X, Tian H, et al. Brain structural and functional dissociated patterns in schizophrenia. BMC Psychiatry 2017;17(1):45.
   PubMed Web of Science ®Google Scholar
• Juckel G. Inhibition of the reward system by antipsychotic treatment. Dialogues Clin Neurosci 2016;18(1):109–14.
   PubMed Web of Science ®Google Scholar
• Kirsch P, Ronshausen S, Mier D, Gallhofer B. The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients. Pharmacopsychiatry 2007;40:196–8.
   PubMed Web of Science ®Google Scholar
• Blum K, Thanos P, Gold M. Dopamine and glucose, obesity, and reward deficiency syndrome. Front Psychol 2014;17(5):919.
   Google Scholar
• Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel L, et al. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuroimage Clin 2015;8:1–31.
   PubMed Web of Science ®Google Scholar
• Newman-Tancredi A, Kleven MS. Comparative pharmacology of antipsychotic possessing combined dopamine D2 and serotonin5-HT1A receptor properties. Psychopharmacology 2011;216:451–73.
   PubMed Web of Science ®Google Scholar
• Bédard AM, Maheux J, Lévesque D, Samaha AN. Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia. Schizophr Bull 2013;39(3):692–702.
   PubMed Web of Science ®Google Scholar
• Elman I, Borsook D, Lukas SE. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006;31(10):2091–120.
   PubMed Web of Science ®Google Scholar
• Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156(11):1686–96.
   PubMed Web of Science ®Google Scholar
• Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005;19(Suppl. 1):1–93.
   PubMed Web of Science ®Google Scholar
• Goh LG, Dhaliwal SS, Welborn TA, Lee AH, Della PR. Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study. BMJ Open 2014;4(2):e004138.
   PubMed Web of Science ®Google Scholar
• Holt RI, Peveler RC. Obesity, serious mental illness and antipsychotic drugs. Diabetes Obes Metab 2009;11(7):665–79.
   PubMed Web of Science ®Google Scholar
• Suvisaari J, Keinanen J, Eskelinen S, Mantere O. Diabetes and schizophrenia. Curr Diab Rep 2016;16(2):19.
   PubMed Web of Science ®Google Scholar
• Ganesh S, Ashok AH, Kumar CN, Thirthalli J. Prevalence and determinants of metabolic syndrome in patients with schizophrenia: a systematic review and meta-analysis of Indian studies. Asian J Psychiatr 2016;22:86–92.
   PubMed Web of Science ®Google Scholar
• Lee JS, Kwon JS, Kim D, Kim S-W, Kim J-J, Kim J-H, et al. Prevalence of metabolic syndrome in patients with schizophrenia in Korea: a multicenter nationwide cross-sectional study. Psychiatry Investig 2017;14(1):44.
   PubMed Web of Science ®Google Scholar
• Teixeira PJ, Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr (Sao Paulo, Brazil: 1999) 2007;29(4):330–6.
   PubMed Web of Science ®Google Scholar
• Lee N, Hall W, Lucke J, Forlini C, Carter A. Food addiction and its impact on weight-based stigma and the treatment of obese individuals in the U.S. and Australia. Nutrients 2014;6(11):5312–26.
   PubMed Web of Science ®Google Scholar
• Pursey KM, Collins CE, Stanwell P, Burrows TL. The stability of “food addiction” as assessed by the Yale food addiction scale in a non-clinical population over 18-months. Appetite 2016;96:533–8.
   PubMed Web of Science ®Google Scholar
• Havermans CR, Janssen T, Giesen J, Roefs A, Jansen A. Food liking, food wanting, and sensory-specific satiety. Appetite 2009;52:222–5.
   PubMed Web of Science ®Google Scholar
• Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 1998;28:309–69.
   PubMed Web of Science ®Google Scholar
• Barch DM. The relationships among cognition, motivation, and emotion in schizophrenia: how much and how little we know. Schizophr Bull 2005;31(4):875–81.
   PubMed Web of Science ®Google Scholar
• Ofir-Eyal S, Hasson-Ohayon I, Kravetz S. Affective and cognitive empathy and social quality of life in schizophrenia: a comparison between a parallel process model and an integrative meditation model. Psychiatry Resl 2014;220(1–2):51–7.
   PubMed Web of Science ®Google Scholar
• Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, et al. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry 2006;18(2):99–105.
   PubMedGoogle Scholar
• Ito H, Kumagai T, Kimura M, Koike S, Shimizu T. Dietary intake in body mass index differences in community-based Japanese patients with schizophrenia. Iran J Public Health 2015;44(5):639–45.
   PubMed Web of Science ®Google Scholar
• Christensen O, Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scand 1988;78(5):587–91.
   PubMed Web of Science ®Google Scholar
• Peet M. International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. Br J Psychiatry 2004;184:404–8.
   PubMed Web of Science ®Google Scholar